Request Deal Involvement
GSK completed the acquisition of BP asset IX from Boston Pharmaceuticals for $2bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Centerview Partners
legal advisors
Sullivan & Cromwell
financial advisors
Evercore
legal advisors
Cleary Gottlieb Steen & Hamilton
or
Principals
target
BOSTON PHARMACEUTICALS (BP ASSET IX / EFIMOSFERMIN)
bidder
GSK PLC
vendor
BOSTON PHARMACEUTICALS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite